Malignant neoplasm of overlapping sites of tongue
ICD-10 C02.8 is a billable code used to indicate a diagnosis of malignant neoplasm of overlapping sites of tongue.
C02.8 refers to malignant neoplasms that occur at overlapping sites of the tongue, which can include various regions such as the anterior two-thirds and posterior one-third of the tongue. These tumors can arise from squamous cells, which are the most common type of cells found in the tongue. The clinical presentation may include symptoms such as persistent sore throat, difficulty swallowing, and changes in speech. Diagnosis typically involves a biopsy to confirm malignancy, followed by imaging studies to assess the extent of the disease. Treatment options may include surgical resection, radiation therapy, and chemotherapy, depending on the stage of the cancer. The prognosis varies based on the tumor's size, location, and whether it has metastasized. Early detection is crucial for improving outcomes, and regular dental check-ups can aid in identifying suspicious lesions.
Detailed pathology reports, imaging studies, and treatment plans are essential.
Management of tongue cancers, including chemotherapy and radiation therapy.
Ensure accurate staging and treatment documentation to support coding.
Surgical notes, pre-operative assessments, and post-operative follow-ups.
Surgical resection of tongue tumors and management of complications.
Document the extent of resection and any reconstructive procedures performed.
Used when a malignant neoplasm of the tongue is surgically excised.
Surgical notes detailing the extent of excision and pathology results.
Otolaryngology specialists must document the surgical approach and any complications.
Common symptoms include persistent sores, difficulty swallowing, changes in speech, and unexplained weight loss.
The TNM system assesses tumor size (T), lymph node involvement (N), and metastasis (M) to determine the stage of cancer, which guides treatment decisions.
